Chronic Obstructive Lung Disease Clinical Trial
Official title:
The Ohio State University COPD Registry
NCT number | NCT00814203 |
Other study ID # | 2007H0248 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 2008 |
Est. completion date | December 2010 |
Verified date | October 2021 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.
Status | Completed |
Enrollment | 9 |
Est. completion date | December 2010 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following: - clinical history-a documented history of COPD, emphysema, or chronic bronchitis; - pulmonary function results (defined as an FEV1/FVC less than 0.7; - radiographic results (high-resolution CT findings of emphysema Exclusion Criteria: - in ability to give informed consent - prisoners - pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Philip Diaz |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease. | |||
Secondary | To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01416701 -
Vitamin D and Chronic Obstructive Lung Disease
|
Phase 4 | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT00202150 -
Primary Care Management/Action Plans for Advanced Chronic Diseases
|
Phase 2/Phase 3 | |
Recruiting |
NCT05227547 -
Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
|
N/A | |
Withdrawn |
NCT02273349 -
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
|
N/A | |
Completed |
NCT00018408 -
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Completed |
NCT02987439 -
COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD
|
N/A | |
Completed |
NCT01950936 -
Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)
|
Phase 2/Phase 3 | |
Completed |
NCT01404000 -
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal
|
Phase 2 | |
Terminated |
NCT03811158 -
The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD
|
N/A | |
Recruiting |
NCT01631162 -
The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
|
N/A | |
Completed |
NCT01596023 -
Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients
|
N/A | |
Completed |
NCT01347931 -
In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency
|
N/A | |
Terminated |
NCT01712854 -
Effects of Symbicort on the Ventilatory Kinematics
|
Phase 4 | |
Completed |
NCT02462343 -
Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD
|
N/A | |
Recruiting |
NCT06090149 -
Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients
|
N/A | |
Recruiting |
NCT02778802 -
Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR
|
N/A | |
Enrolling by invitation |
NCT02278107 -
Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease
|
N/A | |
Completed |
NCT01614951 -
The Pulmonary Protection Trial
|
Phase 4 | |
Completed |
NCT01787097 -
Effect of Symbicort ® on GR in Sputum in COPD
|
Phase 4 |